1Y Close · As of Aug 26, 2026
LigaChem Biosciences operates in the Professional Services sector.
Legal name: LigaChem Biosciences Inc.
In fiscal year 2025, LigaChem Biosciences (141080) reported revenue of 141.6 billion KRW, up 12.4% from 125.9 billion KRW a year earlier.
Operating profit was -106.5 billion KRW and net income was -91.6 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 3.64 trillion KRW, with a P/B of 6.72.
These figures can be verified in the DART filing (receipt no. 20260323001538).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 141.6B | -106.5B | -91.6B |
| 2024 | 125.9B | -20.9B | 7.8B |
| 2023 | 34.1B | -80.8B | -73.7B |
Recent Filings
Semi-Annual Report (2026.06)
Payment and Dispute Resolution
투자판단관련주요경영사항 (LNCB74(B7H4-ADC) 단독 개발)
Checks
3 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-14 | Payment and Dispute Resolution |
| 2026-08-07 | 투자판단관련주요경영사항 (LNCB74(B7H4-ADC) 단독 개발) |
| 2026-08-04 | Large Shareholding Report (General) |
| 2026-08-04 | Officer/Major Shareholder Ownership Report |